| Idiopathic Pulmonary Fibrosis |
1 |
1 |
| NMDA Receptor Antagonist |
0 |
0.7 |
| Receptors |
0 |
0.67 |
| Lung Fibrosis |
0 |
0.58 |
| Lung |
0 |
0.46 |
| Biologic Therapy |
0 |
0.4 |
| Interstitial Lung Disease |
0 |
0.4 |
| Otolaryngology |
0 |
0.28 |
| Clinical Research |
0 |
0.21 |
| Healthcare and Medical Technology |
0 |
0.21 |
| Platelet-Derived Growth Factor |
0 |
0.18 |
| Lung Cancer |
0 |
0.16 |
| Cough |
0 |
0.15 |
| Platelet Count |
0 |
0.15 |
| Chronic Cough |
0 |
0.14 |
| Tyrosine Kinase Inhibitor |
0 |
0.14 |
| Hypertension |
0 |
0.13 |
| Non-Small Cell Lung Cancer |
0 |
0.12 |
| Pulmonary Arterial Hypertension |
0 |
0.12 |
| Small Cell Lung Cancer |
0 |
0.11 |
| Cancer |
0 |
0.1 |
| Colorado |
0 |
0.1 |
| Geriatrics |
0 |
0.1 |
| Health Care Quality, Access, and Evaluation |
0 |
0.1 |
| Intravenous |
0 |
0.1 |
| Monoclonal Antibody |
0 |
0.1 |
| Proton Pump Inhibitor |
0 |
0.1 |
| Small Molecule Inhibitor |
0 |
0.1 |
| Tissue |
0 |
0.1 |
| Tyrosine Kinase |
0 |
0.1 |
| Acute Pain |
0 |
0.09 |
| Airway Smooth Muscle |
0 |
0.09 |
| Genomic Medicine |
0 |
0.09 |
| Heart Failure (HF) |
0 |
0.09 |
| Opioids |
0 |
0.09 |
| Social Determinants of Health |
0 |
0.09 |
| Anti-Tumor Necrosis Factor (Anti-TNF) |
0 |
0.07 |
| Gastric Ulcer |
0 |
0.07 |